The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular

Nils Peters1, Christian Opherk, Adrian Danek

  • 1Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, D-81377 Munich, Germany. mdichgans@nefo.med.uni-muenchen.de.

Insights

Cognitive impairment in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) primarily affects processing speed and executive functions. These deficits are evident early, aiding targeted clinical trial development for small vessel disease.

Area of Science:

  • Neurology
  • Neuroscience
  • Genetics

Background:

  • Subcortical ischemic vascular lesions are linked to cognitive decline and dementia.
  • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a genetic small vessel disease caused by NOTCH3 mutations.
  • CADASIL invariably leads to cognitive deficits and dementia in mutation carriers.

Purpose of the Study:

  • To characterize the specific cognitive abnormalities in individuals with CADASIL.
  • To identify the core cognitive profile associated with CADASIL and small vessel disease.

Main Methods:

  • A cross-sectional study involving 65 NOTCH3 mutation carriers and 30 matched controls.
  • Cognitive assessments included global cognition, executive function, attention, processing speed, and error monitoring.
  • Utilized tests such as the Vascular Dementia Assessment Scale, Stroop, Trail Making Test, and maze task.

Main Results:

  • CADASIL subjects showed significant impairments in timed measures, executive functions (verbal fluency, ideational praxis), and attention.
  • Processing speed was the most affected cognitive domain.
  • Error monitoring was also impaired, though to a lesser extent than processing speed. Recall, orientation, and receptive language were preserved.

Conclusions:

  • Processing speed is the primary cognitive deficit in CADASIL, with secondary impacts on executive performance and attention.
  • This cognitive profile is present early in the disease course.
  • The identified cognitive signature may represent the central cognitive syndrome of small vessel disease and subcortical ischemic lesions, valuable for clinical trial design.
Abstract

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...